These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37499587)

  • 61. The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
    Mohs RC; Beauregard D; Dwyer J; Gaudioso J; Bork J; MaGee-Rodgers T; Key MN; Kerwin DR; Hughes L; Cordell CB;
    Alzheimers Dement; 2024 Apr; 20(4):2752-2765. PubMed ID: 38415908
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment.
    Strikwerda-Brown C; Hobbs DA; Gonneaud J; St-Onge F; Binette AP; Ozlen H; Provost K; Soucy JP; Buckley RF; Benzinger TLS; Morris JC; Villemagne VL; Doré V; Sperling RA; Johnson KA; Rowe CC; Gordon BA; Poirier J; Breitner JCS; Villeneuve S;
    JAMA Neurol; 2022 Oct; 79(10):975-985. PubMed ID: 35907254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.
    Mimmack KJ; Sprague EH; Amariglio RE; Vannini P; Marshall GA
    J Prev Alzheimers Dis; 2024; 11(4):966-974. PubMed ID: 39044507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting.
    Jung NY; Kim ES; Kim HS; Jeon S; Lee MJ; Pak K; Lee JH; Lee YM; Lee K; Shin JH; Ko JK; Lee JM; Yoon JA; Hwang C; Choi KU; Lee EC; Seong JK; Huh GY; Kim DS; Kim EJ
    J Alzheimers Dis; 2020; 74(2):473-490. PubMed ID: 32039853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
    Gonzalez C; Mimmack KJ; Amariglio RE; Becker JA; Chhatwal JP; Fitzpatrick CD; Gatchel JR; Johnson KA; Katz ZS; Kuppe MK; Locascio JJ; Udeogu OJ; Papp KV; Premnath P; Properzi MJ; Rentz DM; Schultz AP; Sperling RA; Vannini P; Wang S; Marshall GA
    J Alzheimers Dis; 2023; 94(1):217-226. PubMed ID: 37212093
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.
    Guo T; Landau SM; Jagust WJ;
    Alzheimers Res Ther; 2021 Oct; 13(1):174. PubMed ID: 34654465
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration.
    Boyle R; Townsend DL; Klinger HM; Scanlon CE; Yuan Z; Coughlan GT; Seto M; Shirzadi Z; Yau WW; Jutten RJ; Schneider C; Farrell ME; Hanseeuw BJ; Mormino EC; Yang HS; Papp KV; Amariglio RE; Jacobs HIL; Price JC; Chhatwal JP; Schultz AP; Properzi MJ; Rentz DM; Johnson KA; Sperling RA; Hohman TJ; Donohue MC; Buckley RF;
    Alzheimers Res Ther; 2024 Jul; 16(1):148. PubMed ID: 38961512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.
    de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R
    Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of molecular tools for diagnosis of Alzheimer's disease that are based on detection of amyloidogenic proteins.
    Kulichikhin KY; Fedotov SA; Rubel MS; Zalutskaya NM; Zobnina AE; Malikova OA; Neznanov NG; Chernoff YO; Rubel AA
    Prion; 2021 Dec; 15(1):56-69. PubMed ID: 33910450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease.
    Senda M; Ishii K; Ito K; Ikeuchi T; Matsuda H; Iwatsubo T; Iwata A; Ihara R; Suzuki K; Kasuga K; Ikari Y; Niimi Y; Arai H; Tamaoka A; Arahata Y; Itoh Y; Tachibana H; Ichimiya Y; Washizuka S; Odawara T; Ishii K; Ono K; Yokota T; Nakanishi A; Matsubara E; Mori H; Shimada H
    J Prev Alzheimers Dis; 2021; 8(4):495-502. PubMed ID: 34585225
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.
    Young CB; Winer JR; Younes K; Cody KA; Betthauser TJ; Johnson SC; Schultz A; Sperling RA; Greicius MD; Cobos I; Poston KL; Mormino EC;
    JAMA Neurol; 2022 Jun; 79(6):592-603. PubMed ID: 35435938
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.
    Leng F; Hinz R; Gentleman S; Dani M; Brooks DJ; Edison P
    J Alzheimers Dis; 2024; 100(3):973-986. PubMed ID: 39031352
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults.
    Ennis GE; Betthauser TJ; Koscik RL; Chin NA; Christian BT; Asthana S; Johnson SC; Bendlin BB
    Alzheimers Res Ther; 2023 Mar; 15(1):55. PubMed ID: 36932429
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
    JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment.
    Chandra A; Valkimadi PE; Pagano G; Cousins O; Dervenoulas G; Politis M;
    Hum Brain Mapp; 2019 Dec; 40(18):5424-5442. PubMed ID: 31520513
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease.
    Klein J; Yan X; Johnson A; Tomljanovic Z; Zou J; Polly K; Honig LS; Brickman AM; Stern Y; Devanand DP; Lee S; Kreisl WC
    J Alzheimers Dis; 2021; 80(3):1051-1065. PubMed ID: 33646153
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
    Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
    J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
    Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
    Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
    J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.